TransMedics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

TransMedics Group (Nasdaq: TMDX), a medical technology company specializing in organ transplant therapy solutions, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. The company's management team will deliver a presentation on Monday, January 13, 2025, at 2:15 p.m. PST (5:15 p.m. EST).

TransMedics, which focuses on transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, will make the presentation available through a live and archived webcast on their investor relations website. Interested parties can access both the presentation and the company's standard investor presentation at https://investors.transmedics.com/.

ANDOVER, Mass.  , Dec. 23, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that members of the management team will present at the upcoming 43^rd Annual J.P. Morgan Healthcare Conference. The presentation will take place on Monday, January 13, 2025, at 2:15 p.m. Pacific Standard Time / 5:15 p.m. Eastern Standard Time.

Event: 43^rd Annual J.P. Morgan Healthcare Conference
Date: Monday, January 13, 2025
Time: 2:15 p.m. PST

A live and archived webcast of the presentation will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/. The Company's standard investor presentation is also available through this link.

About TransMedics Group, Inc. 
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

Investor Contact:
Brian Johnston
Laine Morgan
332-895-3222
Investors@transmedics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-participate-in-the-43rd-annual-jp-morgan-healthcare-conference-302338418.html

SOURCE TransMedics Group, Inc.

FAQ

When is TransMedics (TMDX) presenting at the 2025 J.P. Morgan Healthcare Conference?

TransMedics will present at the J.P. Morgan Healthcare Conference on Monday, January 13, 2025, at 2:15 p.m. PST (5:15 p.m. EST).

How can investors watch TransMedics' (TMDX) J.P. Morgan Healthcare Conference presentation?

Investors can watch the presentation through a live and archived webcast available on the 'Investors' section of TransMedics' website at https://investors.transmedics.com/.

What medical technologies does TransMedics (TMDX) specialize in?

TransMedics specializes in organ transplant therapy technologies for patients with end-stage lung, heart, and liver failure.

Which annual healthcare conference will TransMedics (TMDX) attend in January 2025?

TransMedics will attend the 43rd Annual J.P. Morgan Healthcare Conference in January 2025.